On July 7, 2021 Crescendo Biologics Ltd (Crescendo), a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, reported that senior members of the executive team will be participating at the following events (Press release, Crescendo Biologics, JUL 7, 2021, View Source [SID1234584666]). They look forward to meeting investors to discuss the Company’s business strategy, technology, discovery platform and development programmes.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

William Blair Biotech Focus Conference 2021, 14-15 July 2021
Participation in Panel II – Moving Beyond Monoclonals: The Potential of Multispecific Therapies on 14 July at 11:20 am EDT, 4:20 pm BST
Solebury Trout & Venrock’s 5th Annual EU Investor Tour, 14 July 2021
Presentation at 11:15 am EDT, 4:15 pm BST
LifeSci Private Company Summer Symposium 2021, 21 July 2021
Fireside chat at 9:25 am EDT, 2:25 pm BST
BTIG Virtual Biotechnology Conference, 10 August 2021
Fireside chat at 11:30 am EDT, 4:30 pm BST
If you would like to meet the team at these events, please contact the Company via email at [email protected].

Please refer to individual conference websites for further information and updated schedules.